Literature DB >> 1720602

Different hemodynamic responses between acute and chronic infusion of iloprost (prostacyclin-stable analogue) in severe pulmonary hypertension.

M A Gomez-Sanchez1, C S de la Calzada, C Gomez Pajuelo, J C Tascon, M Alonso, J Andreu, M Aranzana, A de la Fuente.   

Abstract

We report the hemodynamic and clinical effects of acute and chronic administration of iloprost in two patients with severe pulmonary hypertension caused by toxic oil syndrome. We tested the acute effect of progressive increments of iloprost, followed by long-term infusion of the drug during 14 days. The acute response produced an increase in cardiac output and moderate reduction in pulmonary vascular resistance, with no change in pulmonary artery pressure. Nevertheless, a maintained reduction in pulmonary artery pressure and resistance, as well as clinical improvement, was observed after chronic infusion. We conclude that (1) the acute effect of iloprost does not necessarily predict long-term hemodynamic response, and (2) iloprost given in long-term infusion seems to have been an efficacious and safe drug in our two patients, and it opens a new line of treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720602     DOI: 10.1164/ajrccm/144.6.1404

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  2 in total

1.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

Review 2.  Repurposing of medications for pulmonary arterial hypertension.

Authors:  Mark Toshner; Edda Spiekerkoetter; Harm Bogaard; Georg Hansmann; Sylvia Nikkho; Kurt W Prins
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.